Consumer News Weight Loss Drug Zepbound Is Also Effective For Sleep Apnea, Study Finds

Weight-loss drugs are changing. Here’s what to know

Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds experience dramatic weight loss on the medications, and there are indications that ... Read More

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ... Read More

Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too

The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from a large-scale trial show they can treat sleep apnea. Read More

Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ... Read More

Trump strikes deal to lower cost of weight loss drugs

President Donald Trump said Thursday his administration has reached a deal to lower the cost of the blockbuster GLP-1 weight loss drugs, Wegovy and Zepbound — a move that could significantly expand ... Read More

Zepbound vs. Wegovy: Which Obesity Treatment Might Be Right for You?

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) have been making headlines lately. They’re two of the few injectable medications approved specifically for ... Read More

New weight-loss shot shows major fat reduction, but experts urge caution

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ... Read More

Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds

(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ... Read More

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Part of a class of drugs known ... Read More